{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:30Z","timestamp":1793032830501,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100631","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:27:04Z","timestamp":1785886024000},"page":"100631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Performance of a modular robotic cluster matches skilled human operators for complex cell therapy manufacturing tasks"],"prefix":"10.1016","volume":"12","author":[{"given":"Sudeshna","family":"Sadhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schmittlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Wah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunaina","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Uboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta P.","family":"Bhanap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Scheffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Gkitsas-Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan Jeffrey","family":"Retherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Tunuguntla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Melocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Parietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Esensten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100631_bb0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.ijpx.2026.100631_bb0010","article-title":"Cell therapy products are revolutionizing multiple therapeutic areas; to maintain this pace of innovation, manufacturing solutions must adapt","volume":"20","author":"Abraham","year":"2021","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.ijpx.2026.100631_bb0015","article-title":"CAR-T cell manufacturing: Major process parameters and next-generation strategies","volume":"221","author":"Ayala","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcyt.2018.01.005","article-title":"Bioprocessing automation in cell therapy manufacturing: outcomes of special interest group automation workshop","volume":"20","author":"Ball","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijpx.2026.100631_bb0025","first-page":"S42","article-title":"Automation of cell therapy biomanufacturing minimizing regulatory risks and maximizing return on investments","volume":"11","author":"Brindley","year":"2013","journal-title":"BioProcess Int."},{"key":"10.1016\/j.ijpx.2026.100631_bb0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.5966\/sctm.2014-0294","article-title":"Concise review: Process development considerations for cell therapy","volume":"4","author":"Campbell","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0035","article-title":"CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights","volume":"16","author":"Cao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fimmu.2020.00482","article-title":"Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: experience from an academic phase I clinical trial","volume":"11","author":"Castella","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41577-024-01035-3","article-title":"Chimeric antigen receptor T-cell therapy for autoimmune disease","volume":"24","author":"Chung","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0050","article-title":"Bridging process diversity in cell therapies toward standardization of manufacturing workflows","volume":"31","author":"Costa","year":"2025","journal-title":"J. Cell Ther."},{"key":"10.1016\/j.ijpx.2026.100631_bb0055","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.3390\/ijms24076300","article-title":"CAR T cell therapy: a versatile living drug","volume":"24","author":"De Marco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100631_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"'Off-the-shelf' allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ijpx.2026.100631_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101250","article-title":"CAR-T cell manufacturing landscape -- lessons from the past decade and considerations for early clinical development","volume":"32","author":"Dias","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijpx.2026.100631_bb0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fbioe.2020.00811","article-title":"Automation, monitoring, and standardization of cell product manufacturing","volume":"8","author":"Doulgkeroglou","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0075","first-page":"63","article-title":"Scale-out cultivation of human dermal fibroblasts using robotic cell culture system: comparison of manual and automated processing","volume":"11","author":"Fadeyev","year":"2022","journal-title":"Cell. Ther. Transpl."},{"key":"10.1016\/j.ijpx.2026.100631_bb0080","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3389\/fimmu.2019.02361","article-title":"GMP-compliant manufacturing of NKG2D CAR memory T cells using CliniMACS Prodigy","volume":"10","author":"Fern\u00e1ndez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0085","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41409-020-0956-8","article-title":"Value and affordability of CAR T-cell therapy in the United States","volume":"55","author":"Fiorenza","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ijpx.2026.100631_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101114","article-title":"Development of an automated manufacturing process for large-scale production of autologous T cell therapies","volume":"31","author":"Francis","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijpx.2026.100631_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jala.2011.01.002","article-title":"Development of a novel automated cell isolation, expansion, and characterization platform","volume":"16","author":"Franscini","year":"2011","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.ijpx.2026.100631_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2026.100631_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102476","article-title":"Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee","volume":"69","author":"Greco","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ijpx.2026.100631_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcyt.2022.10.002","article-title":"Emerging frontiers in immuno- and gene therapy for cancer","volume":"25","author":"Gustafson","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijpx.2026.100631_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/rme-2017-0103","article-title":"Cell therapy-processing economics: small-scale microfactories as a stepping stone toward large-scale macrofactories","volume":"13","author":"Harrison","year":"2018","journal-title":"Regen. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/rme.14.73","article-title":"The translation of cell-based therapies: clinical landscape and manufacturing challenges","volume":"10","author":"Heathman","year":"2015","journal-title":"Regen. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0125","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3390\/pr11102938","article-title":"Automated production at scale of induced pluripotent stem cell-derived mesenchymal stromal cells, chondrocytes and extracellular vehicles: towards real-time release","volume":"11","author":"Herbst","year":"2023","journal-title":"Processes"},{"key":"10.1016\/j.ijpx.2026.100631_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.913287","article-title":"Toward rapid, widely available autologous CAR-T cell therapy -- artificial intelligence and automation enabling the smart manufacturing hospital","volume":"9","author":"Hort","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.copbio.2020.05.005","article-title":"Challenges and advantages of cell therapy manufacturing under Good Manufacturing Practices within the hospital setting","volume":"65","author":"Iancu","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0140","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00262-014-1568-1","article-title":"Engineered T cells for cancer therapy, Cancer Immunol","volume":"63","author":"June","year":"2014","journal-title":"Immunother"},{"key":"10.1016\/j.ijpx.2026.100631_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/cgt.2014.78","article-title":"Towards a commercial process for the manufacture of genetically modified T cells for therapy","volume":"22","author":"Kaiser","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ijpx.2026.100631_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6750-13-102","article-title":"Large-scale cell production of stem cells for clinical application using the automated cell processing machine","volume":"13","author":"Kami","year":"2013","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.reth.2018.08.004","article-title":"A novel, flexible and automated manufacturing facility for cell-based health care products: Tissue Factory","volume":"9","author":"Kikuchi","year":"2018","journal-title":"Regenerative. Therapy."},{"key":"10.1016\/j.ijpx.2026.100631_bb0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3343\/alm.2023.0382","article-title":"Manufacturing cell and gene therapies: challenges in clinical translation","volume":"44","author":"Lee","year":"2024","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0165","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1089\/hum.2017.111","article-title":"Automated manufacturing of potent CD20-directed chimeric antigen receptor T cells for clinical use","volume":"28","author":"Lock","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijpx.2026.100631_bb0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.18609\/cgti.2020.058","article-title":"Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain","volume":"6","author":"Lopes","year":"2020","journal-title":"Cell. Gene. Therapy. Insights."},{"key":"10.1016\/j.ijpx.2026.100631_bb0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10616-020-00403-w","article-title":"Automated in-process characterization and selection of cell-clones for quality and efficient cell manufacturing","volume":"72","author":"Mantripragada","year":"2020","journal-title":"Cytotechnol"},{"key":"10.1016\/j.ijpx.2026.100631_bb0180","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/rme.09.64","article-title":"Assessing the value of autologous and allogeneic cells for regenerative medicine","volume":"4","author":"Mason","year":"2009","journal-title":"Regen. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0185","doi-asserted-by":"crossref","first-page":"673","DOI":"10.18609\/cgti.2020.071","article-title":"The necessity of automated manufacture for cell-based immunotherapies: a cost-based analysis","volume":"6","author":"McCoy","year":"2020","journal-title":"Cell. Gene. Therapy. Insights."},{"key":"10.1016\/j.ijpx.2026.100631_bb0190","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jcyt.2024.03.010","article-title":"Development of a robotic cluster for automated and scalable cell therapy manufacturing","volume":"26","author":"Melocchi","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijpx.2026.100631_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.057","article-title":"Automated manufacturing of cell therapies","volume":"381","author":"Melocchi","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100631_bb0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.reth.2022.10.004","article-title":"Stress and motivation of cell processing operators: a pilot study of an online questionnaire survey","volume":"21","author":"Mizuno","year":"2022","journal-title":"Regen. Ther."},{"key":"10.1016\/j.ijpx.2026.100631_bb0205","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcyt.2016.05.009","article-title":"Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy","volume":"18","author":"Mock","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijpx.2026.100631_bb0210","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10529-019-02732-z","article-title":"Automation in cell and gene therapy manufacturing: from past to future","volume":"41","author":"Moutsatsou","year":"2019","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.ijpx.2026.100631_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2017.02.199","article-title":"The autostem platform for closed manufacture of bone marrow-derived mesenchymal stromal cells using a closed, scalable and automated robotic system","volume":"19","author":"Murphy","year":"2017","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.ijpx.2026.100631_bb0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41409-022-01866-5","article-title":"Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy\u00ae: real-world experience and cost analysis in India","volume":"58","author":"Palani","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ijpx.2026.100631_bb0225","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e10","article-title":"Recent advances in cell therapeutics for systemic autoimmune diseases","volume":"22","author":"Park","year":"2022","journal-title":"Immune Netw."},{"key":"10.1016\/j.ijpx.2026.100631_bb0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/rme-2016-0040","article-title":"Developing an automated robotic factory for novel stem cell therapy production","volume":"11","author":"Rafiq","year":"2016","journal-title":"Regen. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15051799","article-title":"The new wave of gene and cell therapies across diseases","volume":"15","author":"Rieske","year":"2026","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-024-01139-z","article-title":"Advancements and challenges in CAR T cell therapy in autoimmune diseases","volume":"20","author":"Schett","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0245","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s41591-026-04430-6","article-title":"Resetting autoimmune disease with CAR cell therapies","volume":"32","author":"Schett","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0250","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41551-024-01219-1","article-title":"A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells","volume":"8","author":"Sin","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijpx.2026.100631_bb0255","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11899-019-00522-y","article-title":"Towards automated manufacturing for cell therapies","volume":"14","author":"Smith","year":"2019","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"6","key":"10.1016\/j.ijpx.2026.100631_bb0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/08830185.2022.2067154","article-title":"Scaling up and scaling out: advances and challenges in manufacturing engineered T cell therapies","volume":"41","author":"Song","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ijpx.2026.100631_bb0265","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.xphs.2024.04.016","article-title":"Emerging applications and regulatory strategies for advanced medicines manufacturing - towards the development of a platform approach","volume":"113","author":"Srai","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100631_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10616-007-9091-2","article-title":"Manufacture of a human mesenchymal stem cell population using an automated cell culture platform","volume":"55","author":"Thomas","year":"2007","journal-title":"Cytotechnol"},{"key":"10.1016\/j.ijpx.2026.100631_bb0275","first-page":"SP427","article-title":"The role of automation in meeting the growing demand for CAR T-cell therapies","volume":"29","author":"Tomtishen","year":"2023","journal-title":"Am. J. Manag. Care"},{"issue":"12","key":"10.1016\/j.ijpx.2026.100631_bb0280","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jcyt.2023.07.012","article-title":"Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon platform","volume":"25","author":"Trainor","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijpx.2026.100631_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1447147","article-title":"CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases","volume":"11","author":"Vukovic","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0290","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ijpx.2026.100631_bb0295","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21037\/atm-22-3882","article-title":"A new era of gene and cell therapy for cancer: a narrative review","volume":"11","author":"Wang","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100631_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101224","article-title":"Automated manufacture of \u0394NPM1 TCR-engineered T cells for AML therapy","volume":"32","author":"Yonezawa Ogusuku","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:11:31Z","timestamp":1793031091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"alternative-id":["S2590156726001519"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100631","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of a modular robotic cluster matches skilled human operators for complex cell therapy manufacturing tasks","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100631"}}